ActRIIB-IN-1

Overview

ActRIIB-IN-1, 7-azaindole compound is an orally active activin type II receptor B (ActRIIB) inhibitor with an IC 50 of 1.8 nM. ActRIIB-IN-1 can alleviate weight loss, muscle atrophy and decreased muscle strength caused by tumor cachexia, as well as improve appetite. ActRIIB-IN-1 can be used for the research of cancer cachexia.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > TGF-β Receptor

Product Information

• Catalog No.: HY-183005
• CAS No.: 3039974-31-4
• Molecular Formula: C21H22N6
• Molecular Weight: 358.45
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source